COMPARATIVE STEADY-STATE BIOAVAILABILITY OF CONVENTIONAL AND CONTROLLED-RELEASE FORMULATIONS OF ALBUTEROL

被引：18
作者：
POWELL, ML
WEISBERGER, M
DOWDY, Y
GURAL, R
SYMCHOWICZ, S
PATRICK, JE
机构：
[1] SCHERING PLOUGH CORP,DEPT DRUG METAB & PHARMACOKINET,60 ORANGE ST,BLOOMFIELD,NJ 07003
[2] SCHERING PLOUGH CORP,DEPT CLIN PHARMACOL,BLOOMFIELD,NJ 07003
来源：
BIOPHARMACEUTICS & DRUG DISPOSITION | 1987年 / 8卷 / 05期
关键词：
D O I：
10.1002/bdd.2510080506
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：461 / 468
页数：8
相关论文
共 50 条
[31]   Comparative bioavailability study of two controlled-release pentoxifylline tablet preparations [J].
Yuen, KH ;
Wong, JW ;
Peh, KK ;
Julianto, T ;
Choy, WP .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2000, 26 (07) :803-807
[32]   CONTROLLED-RELEASE FORMULATIONS OF PROPRANOLOL AND VERAPAMIL [J].
DUNN, J .
JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 27 (01) :22-31
[33]   FORMULATIONS FOR CONTROLLED-RELEASE OF FENITROTHION IN WATER [J].
KASSEM, SMI ;
SALEH, MS ;
ALY, MI ;
ELLATIF, MEA .
INSECT SCIENCE AND ITS APPLICATION, 1985, 6 (05) :613-616
[34]   PHARMACOKINETIC CHARACTERIZATION OF CONTROLLED-RELEASE FORMULATIONS [J].
STEINIJANS, VW .
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1990, 15 (02) :173-181
[35]   BUTRIPTYLINE - HUMAN PHARMACOKINETICS AND COMPARATIVE BIOAVAILABILITY OF CONVENTIONAL AND SUSTAINED-RELEASE FORMULATIONS [J].
BOURGOUIN, J ;
GAGNON, MA ;
ELIE, R .
BIOPHARMACEUTICS & DRUG DISPOSITION, 1981, 2 (02) :123-130
[36]   PHARMACOKINETIC STUDY IN STEADY-STATE OF SUSTAINED-RELEASE FORMULATIONS OF THEOPHYLLINE [J].
PEZOA, R ;
GAI, MN ;
GUTIERREZ, C .
ARCHIVOS DE BIOLOGIA Y MEDICINA EXPERIMENTALES, 1987, 20 (02) :R238-R238
[37]   PHARMACODYNAMIC PROFILE OF VERAPAMIL IN RELATION TO ABSOLUTE BIOAVAILABILITY - INVESTIGATIONS WITH A CONVENTIONAL AND A CONTROLLED-RELEASE FORMULATION [J].
HARDER, S ;
THURMANN, P ;
SIEWERT, M ;
BLUME, H ;
HUBER, T ;
RIETBROCK, N .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1991, 17 (02) :207-212
[38]   TRAZODONE CONVENTIONAL AND CONTROLLED-RELEASE FORMULATIONS - PHARMACODYNAMIC EFFECTS AFTER SINGLE AND REPEATED ADMINISTRATION [J].
DEBBAS, NMG ;
ANKIER, SI ;
WARRINGTON, SJ .
CURRENT MEDICAL RESEARCH AND OPINION, 1989, 11 (08) :501-509
[39]   DETERMINATION OF BIOAVAILABILITY OF DIAZEPAM IN VARIOUS FORMULATIONS FROM STEADY-STATE PLASMA CONCENTRATION DATA [J].
BERLIN, A ;
AGURELL, S ;
STROM, S ;
SIWERS, B ;
SJOQVIST, F ;
HIORT, A .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1972, 13 (05) :733-&
[40]   BIOAVAILABILITY OF REGULAR AND CONTROLLED-RELEASE CHLORPHENIRAMINE PRODUCTS [J].
KOTZAN, JA ;
VALLNER, JJ ;
STEWART, JT ;
BROWN, WJ ;
VISWANATHAN, CT ;
NEEDHAM, TE ;
DIGHE, SV ;
MALINOWSKI, R .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1982, 71 (08) :919-923
12345